A Massive Market Opportunity
Water Tower Research hosted InMed’s BayMedica VP, Sales & Marketing Jerry P. Griffin for a fireside chat on July 25. Our chat included an overview of the BayMedica business and its competitive environment; the market dynamics of rare cannabinoids and their disruptive potential in the health & wellness sector; and upcoming catalysts for BayMedica. This report contains a transcript of the conversation, which can be accessed on demand and in the full report. Rare cannabinoids in demand. Although still very early days, there is strong evidence from BayMedica’s own revenue growth profile in recent quarters that select rare cannabinoids are starting to make their mark as critical and desired ingredients in a variety of health & wellness products. InMed’s early disclosure press release of July 20 indicated that BayMedica enjoyed sequential revenue growth, surpassing 100% in each of the last two quarters. Massive market opportunity. Griffin highlighted two reasons why the health & wellness sector presents a massive market opportunity for rare cannabinoids and BayMedica...
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.